he benznidazole is the only drug available for the etiological treatment of Chagas disease in Brazil. The efficacy of this medication in the chronic phase of the disease is limited, and important adverse effects can compromise the patient's compliance to the treatment. The finding of new compounds that either act on the infection or optimize the action of existing medications can offer benefits to patients. Hom...
Background: There is no published information about the use of different protocols to administer a highly diluted medication. Evaluate the effect of different protocols for treatment with biotherapic T. cruzi 17 dH (BIOTTc17dH) on clinical/parasitological evolution of mice infected with T. cruzi-Y strain. Methods: A blind, randomized controlled trial was performed twice, using 60 28-day-old male Swiss mice infe...